BG102864A - Application of phosphonic acid esters for the treatment of functional disorders of the brain and depressions - Google Patents
Application of phosphonic acid esters for the treatment of functional disorders of the brain and depressionsInfo
- Publication number
- BG102864A BG102864A BG102864A BG10286498A BG102864A BG 102864 A BG102864 A BG 102864A BG 102864 A BG102864 A BG 102864A BG 10286498 A BG10286498 A BG 10286498A BG 102864 A BG102864 A BG 102864A
- Authority
- BG
- Bulgaria
- Prior art keywords
- depressions
- treatment
- application
- brain
- acid esters
- Prior art date
Links
- 210000004556 brain Anatomy 0.000 title 1
- 150000003008 phosphonic acid esters Chemical class 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19616471A DE19616471A1 (de) | 1996-04-25 | 1996-04-25 | Phosponsäureester zur Behandlung von Hirnleistungsstörungen und Depressionen |
PCT/US1997/006469 WO1997039756A1 (en) | 1996-04-25 | 1997-04-17 | Use of phosphonic acid esters for the treatment of functional disorders of the brain and depression |
Publications (1)
Publication Number | Publication Date |
---|---|
BG102864A true BG102864A (en) | 1999-09-30 |
Family
ID=7792381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG102864A BG102864A (en) | 1996-04-25 | 1998-10-22 | Application of phosphonic acid esters for the treatment of functional disorders of the brain and depressions |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0896540A1 (id) |
JP (1) | JP2000510455A (id) |
KR (1) | KR20000010611A (id) |
AR (1) | AR006870A1 (id) |
AU (1) | AU2462397A (id) |
BG (1) | BG102864A (id) |
BR (1) | BR9709300A (id) |
CA (1) | CA2252567A1 (id) |
CZ (1) | CZ343498A3 (id) |
DE (1) | DE19616471A1 (id) |
HU (1) | HUP9903366A3 (id) |
ID (1) | ID16678A (id) |
IL (1) | IL126698A0 (id) |
NO (1) | NO984964L (id) |
PL (1) | PL333464A1 (id) |
SK (1) | SK146398A3 (id) |
TR (1) | TR199802137T2 (id) |
WO (1) | WO1997039756A1 (id) |
ZA (1) | ZA973538B (id) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1078370B (de) * | 1958-09-16 | 1960-03-24 | Norddeutsche Affinerie | Schaedlingsbekaempfungsmittel |
US3069312A (en) * | 1960-09-28 | 1962-12-18 | California Research Corp | N-substituted dimethyl 1-carbamoyloxy-2, 2, 2-trichloroethyl phosphonates as insecticidal compositions |
BE632366A (id) * | 1962-05-16 | 1900-01-01 | ||
DE1193044B (de) * | 1963-08-05 | 1965-05-20 | Bayer Ag | Verfahren zur Herstellung phosphorylierter Urethane |
DE2512375A1 (de) * | 1975-03-21 | 1976-09-30 | Bayer Ag | 1-hydroxy-2,2,2-trichloraethan- thionophosphonsaeuredialkylester, verfahren zu ihrer herstellung sowie ihre verwendung als insektizide |
US4950658A (en) * | 1988-12-06 | 1990-08-21 | Board Of Trustees Of Southern Illinois Univ. | Method of medical treatment of Alzheimer's disease |
-
1996
- 1996-04-25 DE DE19616471A patent/DE19616471A1/de not_active Withdrawn
-
1997
- 1997-04-17 KR KR1019980708502A patent/KR20000010611A/ko not_active Application Discontinuation
- 1997-04-17 SK SK1463-98A patent/SK146398A3/sk unknown
- 1997-04-17 CA CA002252567A patent/CA2252567A1/en not_active Abandoned
- 1997-04-17 CZ CZ983434A patent/CZ343498A3/cs unknown
- 1997-04-17 HU HU9903366A patent/HUP9903366A3/hu unknown
- 1997-04-17 EP EP97920431A patent/EP0896540A1/en not_active Withdrawn
- 1997-04-17 TR TR1998/02137T patent/TR199802137T2/xx unknown
- 1997-04-17 IL IL12669897A patent/IL126698A0/xx unknown
- 1997-04-17 WO PCT/US1997/006469 patent/WO1997039756A1/en not_active Application Discontinuation
- 1997-04-17 PL PL97333464A patent/PL333464A1/xx unknown
- 1997-04-17 AU AU24623/97A patent/AU2462397A/en not_active Abandoned
- 1997-04-17 JP JP09538197A patent/JP2000510455A/ja active Pending
- 1997-04-17 BR BR9709300A patent/BR9709300A/pt not_active Application Discontinuation
- 1997-04-24 ZA ZA9703538A patent/ZA973538B/xx unknown
- 1997-04-24 ID IDP971362A patent/ID16678A/id unknown
- 1997-04-25 AR ARP970101724A patent/AR006870A1/es unknown
-
1998
- 1998-10-22 BG BG102864A patent/BG102864A/xx unknown
- 1998-10-23 NO NO984964A patent/NO984964L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2000510455A (ja) | 2000-08-15 |
HUP9903366A3 (en) | 2000-08-28 |
KR20000010611A (ko) | 2000-02-25 |
ID16678A (id) | 1997-10-30 |
AU2462397A (en) | 1997-11-12 |
SK146398A3 (en) | 1999-06-11 |
IL126698A0 (en) | 1999-08-17 |
PL333464A1 (en) | 1999-12-20 |
TR199802137T2 (xx) | 1999-02-22 |
DE19616471A1 (de) | 1997-10-30 |
NO984964L (no) | 1998-12-22 |
AR006870A1 (es) | 1999-09-29 |
WO1997039756A1 (en) | 1997-10-30 |
ZA973538B (en) | 1997-11-18 |
CZ343498A3 (cs) | 1999-02-17 |
CA2252567A1 (en) | 1997-10-30 |
HUP9903366A2 (en) | 2000-07-28 |
BR9709300A (pt) | 1999-08-10 |
EP0896540A1 (en) | 1999-02-17 |
NO984964D0 (no) | 1998-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY121047A (en) | Bicyclo [2.2.1] heptanes and related compounds | |
WO1998020864A3 (en) | Use of selected non-steroidal antiinflammatory compounds for the prevention and the treatment of neurodegenerative diseases | |
SI0725779T1 (id) | ||
IL121170A0 (en) | Compositions for the treatment of dermatological disorders | |
BG103335A (en) | Application of fumaric acid derivatives | |
CA2242865A1 (en) | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol | |
MY120976A (en) | 2-amino-6-(2-substituted-4-phenoxy)- substituted- pyridines | |
CA2199844A1 (en) | Compositions for the treatment of skin disorders | |
CA2415354A1 (en) | Phospholipid derivatives of valproic acid and mixtures thereof | |
BG102818A (en) | D-manitol and method for its preparation | |
IL127146A0 (en) | Transdermal propentofylline compositions for the treatment of alzheimer's disease | |
EP1032556A4 (en) | PHARMACEUTICALLY EFFECTIVE COMPOUNDS AND METHODS OF THEIR APPLICATION | |
BG104179A (en) | Phanquinon administration for the treatment of the alzheimer's disease | |
WO2002005801A3 (en) | Compositions containing diacyltartaric salts of (e)-metanicotine | |
ATE192923T1 (de) | Verwendung von boswelliasäure zur behandlung von hirntumoren | |
IL116828A (en) | Use of 3, 4-diphenyl chromans for the preparation of pharmaceutical compositions for the treatment or prophylaxis of cerebral degenerative disorders | |
AU634003B2 (en) | 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants | |
EP0273310A3 (en) | 5-aryl-3h-1,2,4-triazol-3-ones and their use as anticonvulsants | |
IL130586A0 (en) | IL6RIL6 chimera for the treatment of demyelinating diseases | |
GR3007508T3 (id) | ||
BG102864A (en) | Application of phosphonic acid esters for the treatment of functional disorders of the brain and depressions | |
AU5244998A (en) | Morphogen-induced regeneration of sense perceptory tissues | |
BR9714184A (pt) | Utilização de bonzoillquil-1,2,3,6-tetraidropiridinas | |
IL106917A0 (en) | Compositions for the treatment of skin disorders | |
HUP9903165A3 (en) | Use of amosulalol for the preparation of pharmaceutical compositions treating ocular circulation disorders |